,123 In fact, during the long-term course of endocrine drug resistance in HR+ BC, down-regulation of ERα expression and up-regulation of GPER expression have been identified,72,106 suggesting a potential regulatory mechanism of GPER-induced ERα alterations. This evidence concerns the gene GPER1 and breast cancer.